By proceeding, you agree to our Terms of Use and Privacy Policy.
Featuring 40+ presentations, the event brings together over 300 attendees from leading pharma, biotech and academic organisations designing innovative strategies and technologies for more effective cancer immunotherapy development. The Congress includes... Network with key innovators in Cancer Immunotherapy.
Discuss the latest strategies to harness the immune system for the development of innovative therapeutics.
Gather insights to examine the latest challenges and technological innovations in preclinical and clinical development.
Discover ways to advance your understanding of biomarker development and the tumor micro-environment.
Connect and engage with leaders like Alekhya Pochiraju, Andrew Allen, Antonio Santidrian, Arnaud Amzallag, Aude-Helene Capietto and Bonnie Hammer.
Oxford Global exists to accelerate progress in the healthcare and pharma industry by connecting the right people around the most important issues.
At Charles River, we are passionate about our role in improving the quality of people’s lives.
Reaction Biology provides pre-clinical drug discovery solutions as your trusted partner.
Personalis?is a leader in advanced cancer genomics for enabling the next generation of precision cancer therapies and diagnostics.
Ultivue provides researchers and scientists with multiplex biomarker assays for tissue phenotyping and digital pathology.
As the embodiment of our corporate vision, our name and its structural components are a constant affirmation of who we are, what we do and how we do it.
SomaLogic was founded in 2000 with the goal of improving the well-being and quality of life of every individual by transforming how diseases were detected, diagnosed and managed.
"NeoGenomics Laboratories is a leading cancer diagnostic reference laboratory that has provided high-quality cancer testing and partnership programs to pathologists and oncologists for over 10 years.
Sengenics is a functional proteomics company that leverages its patented KREX protein folding technology to discover autoantibody biomarker signature for drug response prediction, patient stratification and development of companion diagnostics.
Cerba Research is the merge of Barc Lab, Histalim and Cerba Xpert. All 3 entities are part of the Cerba HealthCare group and have decided to join forces under one name.
Ionpath delivers high definition spatial proteomics, revolutionizing tissue imaging and analysis to accelerate discovery and improve human health.
Applied Materials is the leader in materials engineering solutions used to produce virtually every new chip and advanced display in the world.
The decoding of the proteome is revolutionizing the way diseases are diagnosed, treated, and prevented.
We are dedicated to revolutionizing the diagnosis and monitoring of life-altering diseases by advancing the science of epigenetics.
Sapient is an end-to-end biomarker discovery partner for pharmaceutical and biotechnology sponsors, providing solutions from large-scale untargeted discovery screening through development of targeted, quantitative CLIA assays to support drug programs
MLM Medical Labs is a leading specialty and central laboratory with comprehensive research services and diagnostic capabilities in Europe and the United States.
At DermTech we bring precision to the practice of dermatology through non-invasive genomic testing. And we developed the Smart Sticker™ that's making it possible.
Canopy Biosciences®, a Bruker company, empowers innovation by providing access to cutting-edge spatial biology and multi-omic tools so biomedical researchers can drive scientific discovery faster.
BioLizard is an agile bioinformatics and data management consulting company providing tailored solutions to the life sciences industry.
Biocartis is an innovative commercial stage molecular diagnostics (MDx) company providing next generation diagnostic solutions aimed at improving clinical practice for the benefit of patients, clinicians, payers and industry.
Arima Genomics was founded in 2015. Through the efforts of our founders, advisors, investors, collaborators and partners, we sold our first product in 2018.
Fluidigm is now Standard BioTools. A company and a name that reflects our commitment to you and your research … To unleash the power of essential, standardized tools that help the life science industry develop breakthrough medicines faster and better
Fluidigm is now Standard BioTools. A company and a name that reflects our commitment to you and your research … To unleash the power of essential, standardized tools that help the life science industry develop breakthrough medicines faster and better.
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.